1. MARKETS
  2. SECTOR : HEALTHCARE
  3. INDUSTRY : HEALTHCARE SUPPLIES
  4. EVOQ REMEDIES LTD.
Evoq Remedies Ltd.
BSE: 543500

Evoq Remedies Live Share Price Today, Share Analysis and Chart

aboutEvoq Remedies Ltd. is a pharmaceutical company primarily engaged in the trading of pharmaceutical products and raw materials. Based in Ahmedabad, the company operates within the SME segment and focuses on the distribution and supply of pharmaceutical... Read More
Ask AI about Evoq Remedies
1.61-0.08(-4.73%)
12,000
BSE Volume

BSE 16 Nov, 2026 12:04 PM (IST)

Portfolio

Alert

My Notes

Evoq Remedies Stock Price Analysis

Evoq Remedies Technical Analysis

Evoq Remedies EMA & SMA

Bearish-8
0 bullish, 8 bearish
Bullish0
Bearish8
5 Day1.6
10 Day1.6
12 Day1.6
20 Day1.6
26 Day1.7
50 Day1.7
100 Day1.9
200 Day2.5

Evoq Remedies Delivery And Volume

Daily Avg. Delivery Volume %
13 Nov, 2026100.0%
Week100.0%
Month100.0%

Evoq Remedies Active Candlesticks

Marubozu Uptrend Belt Hold Uptrend Closing Marubozu Uptrend Long Line Uptrend
Legend
Positive IndicatorNeutral IndicatorNegative Indicator

Evoq Remedies Resistance and Support

1.67
Pivot
First Resistance1.7
Second Resistance1.7
Third Resistance1.8
First Support1.7
Second Support1.6
Third Support1.6
Day RSI53.5
Day MACD0
Day MFI43.3
Day MACD Signal Line0

Evoq Remedies Beta

1 Month-0.7
1 Year-0.2
3 Month-0.2
3 Year-0.1

Evoq Remedies Price Change Analysis

↓-10.6%
Over 1 Month
LowHigh
1.52.0
↓-11.5%
Over 3 Months
LowHigh
1.42.0
↓-50.3%
Over 6 Months
LowHigh
1.43.7
↓-61.1%
Over 1 Year
LowHigh
1.44.3

Evoq Remedies Shareholding Pattern/ Ownership

Shareholding Summary

Mar 2026
 
NameCategorySharesShares %
Prashant SevantikarPublic2,825,00011.4 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Evoq Remedies Deals - Insider, Bulk, Block and SAST

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
SURYA PRAKASH JETHLIABulkSell15 Jun 20262.64164,000BSE
JANAKI BOOPALAN RAJESWARIBulkSell11 Dec 20252.62128,000BSE
NIRAJ RAJNIKANT SHAHBulkSell08 Dec 20252.79176,000BSE
NIRAJ RAJNIKANT SHAHBulkSell28 Nov 20253.05144,000BSE
NIRAJ RAJNIKANT SHAHBulkSell26 Nov 20253.11144,000BSE
PANCHALBulkSell25 Nov 20253.23184,000BSE
JITEN KUMAR BISWASBulkSell20 Nov 20253.74140,000BSE
NILESH M SUHAGIYABulkPurchase17 Nov 20253.94152,000BSE
NILESH M SUHAGIYABulkPurchase12 Nov 20253.92296,000BSE
JITEN KUMAR BISWASBulkSell12 Nov 20253.92136,000BSE

Evoq Remedies Corporate Actions

Evoq Remedies Board Meetings

Evoq Remedies past and upcoming board meetings.

#Ex-Date
PurposeNotes
130 May 2026
Half Yearly Results(Revised)
210 Oct 2025
Quarterly Results-
306 May 2025
Preferential issue of shares-
429 Apr 2025
OthersInter-alia, to consider 1. Raising of funds upto Rs. 99.00 Crores by way of issue of Warrants. 2. Issuance of Equity shares other than cash through swap of shares. 3. Other business matters. (Revised)
510 Apr 2025
Audited Results-

Evoq Remedies Corporate Filings

Evoq Remedies BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

DateAnnouncement TitleDetailsLinks
15 Oct 2026
Evoq Remedies Ltd - 543500 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (DP) Regulation , 2018
PDF
01 Oct 2026
Evoq Remedies Ltd - 543500 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Approval Of Extension Of Time For Holding 16Th Annual General Meeting ('AGM') For The Financial Year Ended 31St March 2026
Approval of Extension of time for holding 16th Annual General Meeting for the Financial Year ended 31st March, 2026
PDF
30 Sep 2026
Evoq Remedies Ltd - 543500 - Closure of Trading Window
Intimation of Closure of Trading Window
PDF
11 Jun 2026
Evoq Remedies Ltd - 543500 - Corporate Insolvency Resolution Process (CIRP)-Admission of application by Tribunal
Corporate Insolvency Resolution Process (CIRP) - Admission of application by Tribunal
PDF
10 Jun 2026
Evoq Remedies Ltd - 543500 - Corporate Insolvency Resolution Process (CIRP)-Admission of application by Tribunal
Corporate Insolvency Resolution process (CIRP) - Admission of application by Tribunal
PDF

Evoq Remedies - Company Profile

Evoq Remedies Management Structure

Evoq Remedies management structure with salaries, total experience, and qualifications.

NAMEDESIGNATIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Mr. Yogesh M. RajputChief Financial Officer-Mar 25
Nikita JainCompany Secretary-Mar 25

Evoq Remedies Board of Directors

Evoq Remedies Board of directors with salaries, total experience, and qualifications.

NAMEPOSITIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Bhumishth Narendrabhai PatelExecutive Director & MD-Mar 25
Narendrakumar Gangaramdas PatelNon Executive Director-Mar 25
Harsh KothariIndependent Director-Mar 25
Aesha Harsh ShahIndependent Director-Mar 25
Pushpa JoshiIndependent Director-Mar 25
Nikita JainCompany Sec. & Compli. Officer-Mar 25

About the company - Business Profile

Evoq Remedies Ltd. is a pharmaceutical company primarily engaged in the trading of pharmaceutical products and raw materials. Based in Ahmedabad, the company operates within the SME segment and focuses on the distribution and supply of pharmaceutical formulations and chemicals. It serves as an intermediary in the healthcare supply chain, leveraging its network to provide various medicinal products to the market.

Key Points

  • Key Facts:
    • Founded Year: Incorporated in 2010.
    • Headquarters: Ahmedabad, Gujarat, India.
    • Stock Listing: Listed on the BSE SME exchange (Security ID: EVOQ, Code: 543500).
    • Core Management: Bhumishth Narendrabhai Patel serves as the Managing Director.
  • Operations and Resources:
    • The company operates from its registered office at Empire Business Hub, Science City Road, Ahmedabad.
    • As of September 30, 2025, the company reported tangible fixed assets (net) valued at ₹19.27 Lakhs.
    • The company's primary operational focus is on the trading of pharmaceutical goods.
  • Market and Significance:
    • Evoq Remedies operates in a single reportable segment: Trading of Goods.
    • Its business model is centered on the procurement and distribution of pharmaceutical formulations, which is critical for maintaining the supply of medicines to healthcare providers.
  • Financial Overview (Annual and Half-Yearly):
    • Revenue from Operations: For the fiscal year ended March 31, 2025, the company reported a total revenue of ₹1175.67 Lakhs. For the half-year ended September 30, 2025, revenue stood at ₹2,550.00 Lakhs, indicating significant sequential growth.
    • Net Profit: The company reported a Profit After Tax (PAT) of ₹12.82 Lakhs for the full year ended March 31, 2025. For the half-year ended September 30, 2025, the PAT was ₹7.88 Lakhs.
    • Expenditure: Major expenses for the half-year ended September 30, 2025, included the purchase of stock-in-trade (₹2,432.12 Lakhs) and employee benefit expenses (₹3.84 Lakhs).
  • Assets and Liabilities:
    • Share Capital: As of September 30, 2025, the share capital was ₹2,490.00 Lakhs, following changes from ₹7,490.00 Lakhs in March 2025.
    • Total Assets: The total assets as of September 30, 2025, were ₹5,221.50 Lakhs, with current assets comprising the majority (₹5,201.83 Lakhs).
    • Trade Receivables: Trade receivables significantly decreased from ₹861.67 Lakhs in March 2025 to ₹19.04 Lakhs in September 2025.
  • Strategic Initiatives:
    • The company continues to focus on its core trading operations while managing its working capital, evidenced by a significant reduction in trade receivables and an increase in short-term loans and advances (₹3,205.30 Lakhs as of September 2025).

References

  1. Result Oct 2025

Evoq Remedies FAQ

Evoq Remedies today is trading in the red, down by 4.73% at ₹1.61.
Evoq Remedies is currently trading down 4.73% on an intraday basis. In the past week the stock rose 3.21%. Stock has been down 11.54% in the past quarter and fell 61.11% in the past year. You can view this in the share price history/seasonality section.
Evoq Remedies is listed on BSE with ticker 543500. It's currently trading on BSE at a share price of ₹1.61.
The market cap of Evoq Remedies is ₹4.01 Cr. as of Nov 16, 2026.
Evoq Remedies has never announced any dividend since the time of its listing on the BSE exchange.
Evoq Remedies has never issued stock splits or bonus shares since the time of its listing on the BSE exchange.
Evoq Remedies reported ₹26.76 Cr. in revenue, ₹-0.24 Cr. in net profit, and ₹-0.2 Cr. in EBITD as of Mar 31, 2026 for FY25-26.
There are no analyst predictions for stock price target for Evoq Remedies.
The PE ratio of Evoq Remedies is -16.71 as of Nov 16, 2026.
The PB ratio of Evoq Remedies is 0.09 as of Nov 16, 2026.
There are no analyst reports for Evoq Remedies.
You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.